BIOELECTRIC MEDICAL SOLUTIONS, INC. APPOINTS GARY WALD TO ITS BOARD OF ADVISORS

San Diego, Ca – April 7, 2004 – Bioelectric Medical Solutions, Inc. (BMSI) today announced the addition of Gary Wald, a former executive at Medtronic, Inc. to their board of advisors. Wald is a senior marketing and business development executive and consultant with over 20 years experience leading the launching and branding of major products, professional services and Intellectual Property.

"Chronic pain plagues millions of people in this country. I am proud to be associated with a company pioneering solutions that help the masses manage, control and alleviate pain," said Wald.

“Gary Wald brings to the company invaluable expertise and skills in marketing, branding, commercialization of major products, and strategic partnerships”, said Peter Lathrop, President & CEO of the company. “Gary will make a very substantial contribution to the company’s marketing strategic business unit as an advisor. His reputation and broad knowledge will be an important asset to the company. We are very excited to have him on our team.”

Bioelectric Medical Solutions, Inc. (“BMSI”) is a biomedical research, development and marketing company that designs, develops and delivers bioelectric consumer healthcare products intended to address and alleviate the effects of acute and chronic diseases states. The company has several non-invasive bioelectric products currently in development to treat pain and its underlying injury, Carpal Tunnel Syndrome (CTS), and Herpes Simplex. BMSI’s breakthrough technology addresses multiple diverse pathologies and is at the forefront of today’s medical technology. BMSI can be found on the web at www.biomsi.com.

.